Showing 1 to 5 of 5 results
Narcotics Found in Turkish Higher Education Official's Vehicle
Narcotics were found in a Turkish Council of Higher Education (YÖK) vehicle assigned to Fehmi Şimşek, deputy chief of staff and brother of a high-ranking parliament official; despite a parliamentary inquiry ten months later, no action has been taken against Şimşek, prompting allegations of a cover-u...
Narcotics Found in Turkish Higher Education Official's Vehicle
Narcotics were found in a Turkish Council of Higher Education (YÖK) vehicle assigned to Fehmi Şimşek, deputy chief of staff and brother of a high-ranking parliament official; despite a parliamentary inquiry ten months later, no action has been taken against Şimşek, prompting allegations of a cover-u...
Progress
52% Bias Score
GLP-1 Drugs Show Promise in Treating Alcohol Addiction
A new study suggests that the diabetes drugs Ozempic and Wegovy may also help reduce alcohol consumption in individuals with alcohol use disorder, offering a potential new treatment avenue.
GLP-1 Drugs Show Promise in Treating Alcohol Addiction
A new study suggests that the diabetes drugs Ozempic and Wegovy may also help reduce alcohol consumption in individuals with alcohol use disorder, offering a potential new treatment avenue.
Progress
0% Bias Score
FDA Proposes Removing Phenylephrine from Decongestants
The FDA proposes removing oral phenylephrine from over-the-counter nasal decongestants due to ineffectiveness, sparking debate among healthcare organizations.
FDA Proposes Removing Phenylephrine from Decongestants
The FDA proposes removing oral phenylephrine from over-the-counter nasal decongestants due to ineffectiveness, sparking debate among healthcare organizations.
Progress
0% Bias Score
Lecanemab: EMA Approval and Limitations
EMA approves Lecanemab, a new Alzheimer's drug targeting amyloid plaques, but with limitations due to side effects and treatment complexity.
Lecanemab: EMA Approval and Limitations
EMA approves Lecanemab, a new Alzheimer's drug targeting amyloid plaques, but with limitations due to side effects and treatment complexity.
Progress
0% Bias Score
New NHS Drug and the Brain-Damaging Effects of Smoking
A new NHS drug, Varenicline, promises to help thousands quit smoking. However, smoking significantly impacts brain health, accelerating aging and increasing the risk of neurodegenerative diseases.
New NHS Drug and the Brain-Damaging Effects of Smoking
A new NHS drug, Varenicline, promises to help thousands quit smoking. However, smoking significantly impacts brain health, accelerating aging and increasing the risk of neurodegenerative diseases.
Progress
0% Bias Score
Showing 1 to 5 of 5 results